Mimedx Group Inc (MDXG) Stock Price, Quote & News

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology

Sector: Healthcare

Phone: 770 651 9100

Website: www.mimedx.com

Address:

1775 West Oak Commons Court, NE, Marietta, United States

WarrenDouglasTrader Aug. 22 at 10:16 PM

$MDXG So, with new acquisition, revs will exceed 400mm in 2027......applying a 5x multiple means 2b mkt cap.....which is over 3X from today, i.e $12-13 per share.....a buyer could easily pay $15. This is very undervalued. Especially since surgical is growing and CMS reform will eventually occur.

1 · Reply

GlobalInsights Aug. 22 at 1:29 AM

$MDXG SLZS up a lot already but binary event coming that will either triple the stock or send it down 80% https://finance.yahoo.com/markets/stocks/articles/sls-stock-clocks-three-straight-211931656.html

0 · Reply

biomaster22 Aug. 21 at 11:56 PM

$MDXG does anybody post about Mdxg other than this idiot Warran Douglas

2 · Reply

WarrenDouglasTrader Aug. 17 at 7:04 PM

$MDXG

0 · Reply

WarrenDouglasTrader Aug. 17 at 1:21 PM

$MDXG https://www.streetinsider.com/dr/news.php?id=26935000

0 · Reply

77HighStreet Aug. 16 at 2:15 PM

$MDXG Does Sanara’s OsStic already have traction here in the US?

0 · Reply

FORECAST_ONE Aug. 14 at 3:39 PM

$ONFO 🔥 insane trade from early entries! 🔥 Monster trade with cord members! Gave early entries at $2.85, then added $3.20 for those who missed the initial entry both hitting $6.08! $2.85 → $6.08 = +113.33% Nearly 2X from the $3.20 add and more than 2X from the original entry! 🟢💸🎯 Early entries, patience, scaling, and letting the chart work. What a way to close out the week! You dont want to miss the next one! $WETO $MDXG $VBIO charting

0 · Reply

MS_Tammy Aug. 14 at 2:08 PM

$GP Buy GP people..no risk no reward.. Most probably ER and PR next week .. Last ER was a killer.. # Revenue: $8.5 million, the highest quarterly revenue in the previous eight quarters. # The company returned to profitability after several quarters of losses. # EPS: +$1.32, versus -$1.66 a year earlier... $WETO $CAPR $MDXG

3 · Reply

WarrenDouglasTrader Aug. 8 at 12:49 AM

$MDXG

0 · Reply

Mouton_Noir Aug. 7 at 1:46 PM

$MDXG one thing orgo quietly inserted into their ER - issuing ATM capital raise. At today's prices, they would be adding 43 million shares to their float. They have less than 6 months of cash at current burn rate. The raise gives them another 6-8 months at the cost of 25%+ dilution. favorite comment from CEO - 'many of the remaining players are diversifying away from wound care or exiting the category altogether. organogenesis is doubling down on wound care'. Yikes.

1 · Reply

MiMedx price target raised to $7 from $5 at Lake Street

SMTI

2026-07-29T21:05:31.000Z - 25 days ago

MiMedx to acquire Sanara MedTech for $35 per share, $350M enterprise value

SMTI